Cutera
CUTR

$1.52

6.43%

Market Cap: 30.5M

About: Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment.

Employees: 430

Healthcare Electromedical & Electrotherapeutic Apparatus

0

Funds holding %

of 6,702 funds

0

Analysts bullish %

of 4 analysts

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

12% less funds holding

Funds holding: 99 [Q4 2023] → 87 (-12) [Q1 2024]

20.16% less ownership

Funds ownership: 86.55% [Q4 2023] → 66.39% (-20.16%) [Q1 2024]

43% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 28

50% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 38

63% less call options, than puts

Call options by funds: $631K | Put options by funds: $1.68M

68% less capital invested

Capital invested by funds: $60.9M [Q4 2023] → $19.5M (-$41.5M) [Q1 2024]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q4 2023] → 0 (-1) [Q1 2024]

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$3

97%

upside

Avg. target

$8.25

443%

upside

High target

$10

558%

upside

4 analyst ratings

3 positive

75%

1 neutral

25%

0 negative

0%

Stephens & Co. George Sellers	558%upside $10	Overweight Reiterated	25 Jun 2024
Piper Sandler Matt O'Brien	97%upside $3	Neutral Maintained	21 Jun 2024
Stephens & Co. George Sellers	558%upside $10	Overweight Reiterated	22 Mar 2024
Stephens & Co. George Sellers	558%upside $10	Overweight Reiterated	6 Mar 2024

See Analyst Rankings

Financial journalist opinion

Cutera® to Announce Second Quarter Results on August 8, 2024

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the second quarter ended June 30, 2024, after the market closes on Thursday, August 8, 2024. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m ET) that same day. Participants can register for the conference call by following registration link.

Cutera® to Announce Second Quarter Results on August 8, 2024

Investor Alert: 3 Ugly Celebrity Beauty Brand Stocks Not Worth Your Dollar

Celebrity beauty brand stocks can be exceptionally exciting prospects when first looking at them. After all, they have the endorsement of celebrities to build advertising off of, which tends to get people in the door early on.

Cutera® Announces New Survey Data During Acne Awareness Month

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces the release of important new acne survey data as part of June's Acne Awareness Month. The findings highlight the impact of acne on individuals and emphasize the substantial role of novel treatments like AviClear®, the first FDA-cleared energy-based device for the long-term treatment of mild, moderate, and severe inflammatory acne, in improving quality of life. Cut.

Cutera® Announces New Survey Data During Acne Awareness Month

Cutera® Appoints Jeryl L. Hilleman to Board of Directors

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that Jeryl “Jeri” Hilleman will join its Board of Directors, effective July 12, 2024. Ms. Hilleman brings over 30 years of experience in the healthcare industry, with a proven track record in financial leadership, strategic planning, operational excellence, and corporate governance. Her extensive background in life sciences and medical technology, both as a.

Cutera® Appoints Jeryl L. Hilleman to Board of Directors

The 3 Most Undervalued Meme Stocks to Buy in June 2024

While the rampant speculation that underlines the meme-trading phenomenon may be viewed as problematic, this sector may also provide some hidden gems. The key is to consider fundamentally sound enterprises that happen to be trading below their intrinsic worth.

The 3 Most Undervalued Meme Stocks to Buy in June 2024

Cutera® Announces AviClear® Investor Webinar

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will hold an investor webinar at 11 a.m. PDT on June 20, 2024, to present an overview of AviClear, the first FDA-cleared energy device for the long-term treatment of mild, moderate, and severe inflammatory acne. The webinar will include a review of clinical data, market opportunity, future clinical studies, and real-world user experience. The AviClea.

Cutera® Announces AviClear® Investor Webinar

If You Can Only Buy One Meme Stock Now, It Better Be One of These 3 Names

Deep in one of the more passionate and hyperbolic corners of the internet exists a community of investing subReddits. What once existed as a public forum for discussing stock prospects and company valuations has now evolved into several different pockets of speculative fervor.

If You Can Only Buy One Meme Stock Now, It Better Be One of These 3 Names

Trade of the Day: Cutera (CUTR) Stock Presents a Short Squeeze Opportunity

At a quick glance at its one-year chart, seemingly everything about dermatology specialist Cutera (NASDAQ: CUTR ) screams danger. Typically, a publicly traded firm doesn't lose over 88% of its market value over a 52-week period unless something catastrophic happens.

Trade of the Day: Cutera (CUTR) Stock Presents a Short Squeeze Opportunity

Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, granted a total of 44,500 non-qualified inducement stock options to six employees. These awards were approved by the Compensation Committee of Cutera's Board of Directors. The stock options have an exercise price of $2.23, equal to the closing price of Cutera common stock on the grant date of May 13, 2024. A quantity of 25% shall vest annually, a.

Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Cutera, Inc. Investor Alert (NASDAQ: CUTR): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors

SAN FRANCISCO , May 21, 2024 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Cutera, Inc. investors that the firm is investigating potential legal claims arising from recent accounting issues, a restatement of the company's financials, and other potential wrongdoing. Current shareholders are encouraged to contact the firm regarding their rights.

Cutera, Inc. Investor Alert (NASDAQ: CUTR): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors

See News Rankings